Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion type Assertion NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_head.
- NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion description "[Serum thiobarbituric acid reactive substances concentration and aortic superoxide anion concentration were estimated to assess oxidative stress.8-Br-cAMP (5 mg/kg, i.p.) or atorvastatin (30 mg/kg, p.o.) prevented hypertension-induced attenuation of acetylcholine-induced endothelium-dependent relaxation, impairment of vascular endothelial lining, decrease in expression of mRNA for endothelial nitric oxide synthase (eNOS), serum nitrite/nitrate concentration and increase in expression of mRNA for p22phox, superoxide anion and serum TBARS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_provenance.
- NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion evidence source_evidence_predicted NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_provenance.
- NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion SIO_000772 17109653 NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_provenance.
- NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion wasDerivedFrom rgd-2016 NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_provenance.
- NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_assertion wasGeneratedBy ECO_0000218 NP60637.RAvNBbw_w533ZE3d5fo6Xq8jh5IcxfCpyPcF9YKAF9Hbc130_provenance.